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The immortalized human keratinocyte cell line Ha-
CaT was used to assess the effect of interferon-y 
(IFN-y) on expression of keratin K17. Both IFN-y and 
K17 have been implicated in the pathophysiology of 
psoriasis. Western and quantitative enzyme-linked im-
munosorbent assay analyses demonstrated increasing 
induction of K17 protein by 48 h exposure to IFN-y at 
concentrations of 10, 50, and 250 Vlrnl. At 50 V lml 
IFN-y, immunohistochemical analysis revealed numer-
ous K17-positive foci, whereas ill situ hybridization 
demonstrated K17 message in the majority of cells. In 
T he molecular events that play ca usal roles in the pathogenesis of psoriasis remain poorly understood [1.]. Clea rly, severa l major mechanisms interact, in-cluding the inflammatory response [2] and the repro-gramming of keratinocyte differentiation that res ults 
in the predominant features of psoriasis, namely epidermal hyper-
plasia and h yperkeratosis [3] . It has been suggested that various 
cytokines may play significant roles in psoriasis pathophysio logy, 
obviously by eliciting the important immunologic responses [4], 
and also possibly by eliciting abnormal keratinocyte differentiation, 
detectable by aberrant expression of specific keratinocyte differen-
tiation markers [5]. 
To address this latter possibility, the effect of interferon-')I 
(IFN-')I) on keratin K17 protein expression was assessed ;11 11;11'0. 
IFN-')I was chosen for study because it has been shown to indu ce 
certain features of psoriasis ;/1 lIitl'o, such as human le ukocyte 
antigen-DR and IL-I0 expression ill normal keratinocytes [4 ,6,7]. 
Furthermore, IFN-')I activity ;11 11;110 has been demonstrated in 
psoriatic plaques [8,9], probab ly released by infiltrating activated T 
lymphocytes [2,4], and IFN-')I Call induce psoriatic-like lesions at 
skin injection sites [10]. K17 was chosen because tlus keratin is 
lughly expressed in psoriatic p laques [5] , whereas normally K17 is 
expressed only in internal epithelia, specific skin appendages, or 
developing interfollicular epidermis [11-13]. 
Because human primary keratinocytes express lugh levels ofK17 
ill lI;lro, w luch is unaffected by IFN-')I treatment (Bonnekoh ci ai , 
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addition, at low (5 V lml) concentrations ofIFN-y, cell 
proliferation and protein synthesis decreased, as de-
termined by 3H-thymidine labeling and 14C-amino 
acid uptake. These data suggest that aberrant K1 7 
expression observed in psoriatic lesions may be a 
consequence of IFN-y overexpression, and that the 
HaCaT cell line may be a useful in vitro model system 
to elucidate the underlying mechanisms. Key words: 
type II illteiferolllill vitroldijfere1ltiatiolllpsoriasis. ] Invest 
Dermatol 104:58-61, 1995 
unpublish ed data), we assessed the effect of IFN-')I on K17 expres-
sion in the HaCaT cell line . HaCaT cell s are 3n immortalized 
human keratinocyte lin e [14], well chara cterized as an ;11 11;/1'0 model 
system for experimental hyperproliferation [15], and have the 
advantage of low levels of endogenous K17 expression . Previously, 
by using e pithelial cell lines, including HaCaT, to identify IFN-')I-
indu cible genes, investigators identified a 1.6-kb ml~A, desig-
na ted 39.1 [16] . Th is was later shown to be a type 1 keratin with 
lug h homology to K17 [1 2] . Using speci fi c anti-K17 antibodies, we 
now confirm K17 induction by IFN-')I, quantitated at the protein 
level. Although an ill 11;/ 1'0 system was used, these data suggest that 
anomalous IFN-')I production i.11 psoriatic lesions can alter the 
expression of specifi c keratin difFerentia tion markers. 
MATERIALS AND METHODS 
Cell Culture and IFN-l' Treatment Ha CaT keratillocytes were grown 
routinely in Dulbecco's modif,ication of Eagle's medium (Flow, Meckcn-
heim , GermallY) supplemented with 101Y., feta l bovine scrum as described 
r14 ,15J. For IFN-y treatment, cell s were exposed at concentnltions of5 to 
1250 U/m l IFN-y (Bioferon, L"upheim, Germany). For Western analys is, 
keratins were extracted from con Auc ll t culturcs after 48 h incubation with 
I FN-y. In thc cu lture-plate-dirccted " Ika ljnc phosphat"se-anti-a lka linc 
phosphatase enzymc- lin kcd il11munosorbcnt "ssay (APAAP ELISA) tec h-
niquc, 1.5 X 10" HaCaT ce ll s werc seeded per wel l on a 96-well pl"te; at 
conA uence 24 h I"ter, the ce ll s wcre exposed to II' N-y alld ELISA was 
performed after 48 h . To determine DNA and protein synthcsis, 4 X 10" 
HaCaT ce ll s were p l"tcd per wel l in a 24-well multidish , and 24 h la ter 
subcon Auent cultures were illcub"ted with I.FN-y for 48 h. At thjs time, 
cultures were pu lse-I"beled sim ultaneo usly for 2 h with '1. 0 !LCi mcthyl-
JI-I-thym idinc and 0.5 !LCi "'C-I"beled "m in o acids. The ce lls were 
harvested and preparcd for measurement in a Rackbeta scinti ll ation counter 
(LKJ3, Bethesda, MD) /1 5], and total prote in was determined by the 
Bradford assay (Biorad L"boratories, Hercules, CAl [17] . In add ition, the 
effect of high-dose IFN-y on HaCaT ce ll viability was assessed by tryp"n 
b luc exclusion and dctermin"tion of I"ctate dehydrogcnase release (LDH). 
For the hitter, after 48 h H aCaT cul ture media were processed for 
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photometric determination ofLDH activity by a Boehringer Mannheim test 
kit [15] . 
Western Analysis IFN-y-treated HaCaT cells were trypsinizcd and 
pclleted, and keratins were extracted as described [18]. Extracted keratins 
were solubilized in 63 mM Tris (pH 7.4)/160 111M sodium dodecylsul-
f.1 te/2% J3-mercaptoethanol (v /v ), and separated by 12% sodium dodecyl-
sul fate-po lyacrylamide gel electrophoresis (40 /-Lg protein per lane) [19]. 
After the transfer to nitrocellulose. the filter was incubated with mouse 
monoclonal anti-human K17 antibody (anti-KI7, clone 17.E3, Progen , 
Heidelberg, Germany; dilution 1:10) [13], and the bands were visualized by 
the standard indirect pero>.;dase teclmique [17]. Coomassie-blue-stained 
gels and K17 immunoblots were photographed for dcnsitometric analysis 
and semiquantitated using an LKB 2202 UltraScan laser densitometer. 
Quantification of K17 Expression by a Culture-Plate-Dire'cted 
APAAP ELISA Technique K17 expression was analyzcd by a modified 
ELISA teclmique, esscntially as described previously [20] . Briefly, after 
IFN-'Y treatment the cultures were treated with 0.05% saponin (Serva, 
Heidelberg, Germany)/50 mM Tris buffer, pH 7.4 (w / v), for 10 min at 
37°C, and fixed in ice-cold 50% acetone/ 50% ethanol for 5 min. The cell s 
were then incubated with anti-Kl7 antibodies (diluted 1 :50) and subse-
quently with rabbit anti-mouse immunoglobulins (Dakop"tts , Copenhagen, 
Dcnmark; 1 :50), fo llowed by addition of the APMP complex (Dakopatts; 
1 :100). The plates were developed by incubating with 200 /-Lliwell of a 
solution containing 79 mg p-nitrophenyl phosphatc (Sigma Chemical Co., 
St. Lou.is , Mo.) and 33 mg levamisole (Sigma) dissolved in 58 ml of 
Tris-NaCI (0.87% NaCl, 0.15% Tris-H C l, 0.49% Tris-base pH 8.8 [w /v ]) 
and 21 ml of 0.2 M 2-amino-2-methyl-l,3-propa-diol (Serva). T he reaction 
was stopped after 30 min by addition of 50 /-Ll 3 M NaOH per well. T he 
concentration of the p-nitrophenol product was measured by absorbance at 
405 nm using an immunorcader, and results were related to the cell number 
per well (relative units/ l0· cell s). 
Immunohistochemical Analysis and [" Sit" Hybridization HaCaT 
keratinocytes grown on Lab-Tek chamber slides (Nunc, Naperville, lL) 
were incuba tcd for 48 h with 10, 50, 250. or 1250 U/ ml IION-y. and then 
fixcd with icc-cold 50% ethanol and 50% acctone (v /v ). Immunohisto-
chemistry was performcd using anti-Kl7 antibodies (dilution 1 :40) . and the 
reaction was visuali zed by the APAAP technique described above (Dako-
patts). 
At 48 h, parallel HaCaT cultures were fixed with 4% para formaldehyde , 
and ill sitll hybridization was performed as described [21]. Briefl y, a 
Kl7-specifi c, 240-bp anti-sense oligonucleotidc was used (K17 sequence 
position 184-424 [12]). and tile corresponding sense sequence servcd as a 
ncgative control probe. III "jim transc';ption was pcrformed with 40 /-LCi 
35S_UTP (Amersham. Braunschweig. Germany) . Slides wcre incubated for 
3 h at 50°C using 10" cpm labeled anti-sense or sense RNA probe per 
section, in a mixture of 55% (v/v) formam ide, 2 X sodium citrate/ sodium 
chloride buffer (SSC) (1 X SSC = 0.15 M NaCl , 15 mM Na-citrate, pH 
7.0) , sa lmon sperm DNA (1 /-Lg / /-L l) , ycast tI'tNA (1 /-Lg / /-Ll). and bovine 
serum albumin (2 /-Lg/ /-LI) . To remove un hybridized probe. slides were 
washed with 2 X SSC/50% formamide at 52°C and digcsted with l'tNase A 
(1 /-Lg/ ml). Autoradiography was performed at 4°C USiJlg NTB2-film 
emulsion (Kodak, Stuttgart. Gennany) for 7 or 14 d. respectively. 
Statistical Analysis Statistical probabilities wcre obtained by the U test 
with a level of significance of 0.05. Multiple comp:n-isons required Bonfer-
roni's adjustment [1 5]. This statisti ca l analysis was applied to the data from 
seven independent Western blots, six separatc ELISA experiments, and 
three independcnt proliferation assays . reprcsenting 36 cultures for each 
IFN-'Y concentration assessed. 
H.ESULTS AND DISCUSSION 
To investigate whether specific cytokines could inAue nce the 
expression of keratinocyte differentiation marke rs implicated in 
psoriasis, we incubate d the inul10rtaLized keratinocyte line BaCaT 
with IFN-')'. As shown previously, IFN- 'Y induced a 1.6-kb mRNA 
with high homology to K17 [16], and given that K17 express ion is 
a marker for the psoriatic state [5], IFN-,),-treated BaCaT cells 
were assessed for K17 prote in induction by specific antibodies. 
Western analysis (Fig 1A) demonstrate d that the low basal level of 
K17 expression observed in conAuent cultures increased on treat-
ment ofBaCaT cells with low (10 U / ml) doses of IFN-,), for 48 h . 
Repeate d W este rn blots demonstrated induction of K17 in a 
dose-d ependent manne r until doses exceeded 250 U / ml IFN-')' 
(Fig 1A). Semiquantitative densitometric analysis of Western blots 
INDUCTION OF KEI~TIN 17 BY INTERFERON-), 59 
A 
46kD- _- -_ .......... 
B 
-e 
"E 
o (J 
'0 
~ 
c: 
o 
'iii 
~ 
a. 
x 
QJ 
r--. 
..-
650 
550 
450 
350 
250 
c: 150 ~ 
10 50 250 1250 
c IFN-"( (U/ml) 
QJ ............... . . . ... . ........ ... ...... ......... .. . . .. .. . . 
~ 
50 
10 100 1000 
IFN-y (U/ml) 
Figure 1. Western and quantitative analyses of K17 induction by 
IFN-'Y' A) W estern blot of keratins extracted from confluent HaCaT cells 
exposed for 48 h to the concentrations of IFN-'Y indicated, probed with an 
anti-K17 antibody. Note induction of K17 protein over 10, 50. and 250 
U / ml of IFN-y but little obvious increase at higher concentrations. B) 
Culture-plate APAAP ELISA analysis to quantitate K17 e>''Pression per 1 O' 
cells, measured by relative absorbance at 405 nm compared to untreatcd 
conttols. Data are pooled from six separate experiments at each IFN-y 
concentration. Note a two- to tllreefold induction of KI7 up to 250 U/ ml 
and a continued increase at 1250 U / ml, but with a significant increase in the 
standard deviation. 
demonstrated an approximately twofold increase in K17 expression 
levels over basa l levels at 10 U / ml , increasing to approximately 
three fold at 250 U / ml. These significant results are in agreem ent 
with the two- to fivefold indu ction of the 1 .6-kb K17 mRNA 
observed previously by treatment of BaCaT cells with IFN-')' [16] . 
To quantitate K1 7 induction accurately, a culture -plate APAAP 
ELISA was designed . Using this sensitive technique, an approxi-
mately tIU"eefold induction ofK17 was observed over a dose range 
of10 to 250 U / ml (Fig 1B), and statistical analysis of36 dish es per 
concentration in six separate expe riments gave a significant p value 
of 0.05. Unlike Weste rn analysis, th.is ELISA-based technique 
demonstrate d an increase in K17 expression above 250 U/1111, albeit 
with a large variation in standard deviation at high IFN-')' doses 
(Fig 1B). This variation may be due, in part, to the effects oflFN-,), 
cytotoxicity, which was obse rved morpholog ically and by trypan 
blu e exclusion analysis at concentrations g rea ter tIlan 400 U/ml 
(not shown). We attempted to quantify th e effects of cytotoxicity 
by assessing LDB re lease. A lthough this assay detecte d a w ide 
variation of LDB re lease in repeated control dishes and IFN-')' 
trea tments up to 250 U / ml, the increase in LDH re lease above 400 
U l ml was found to b e statistically significant (p = 0.05, not 
shown). 
T he continu ed increase in K17 prote in levels expressed as a 
fun ction of cell number observed in the ELISA (Fig iB) is 
intrig uing and ra.ises the possibility that, as keratin tran scripts are 
relatively stab'! e [22] and IFN-')' exerts an antiproliferative effect 
(below), this result derives from translation of accumulate d K17 
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Figure 2. Immunohistochemical analysis ofK17 expression. A) J{17 cxprcssion in conflucnt HaCaT cells treatcd with 50 U/ mIIFN-y for 48 h. Note 
thc foca l naturc of thc intense K17 cxpression compared to thc low levels in surroundi ng cclls. Numcrous foci wcre also obtained at doses of 10 and 250 
U/ mL B) Low-Icvel K17 exprcssion in control, untreated confluent H:aCaT cell s. Bnr, 3.5 /-Lm. 
mRNA. That a post-transcriptional m echanism may exist in t he 
regu lation of K 17 protein expression is strengthen ed by a compar-
ison of K17 immuno histochemical analys is (Fig 2) and ill s itu 
hybridization (Fig 3) . An anti-K17 antibody analysis of HaCaT 
ce Us treated w ith 50 U / m] IFN-')' revea led numerous K17-positive 
foci throughout the confluent m onolayer (Fig 2A). T hese foci 
expressed hig h levels ofK17 protein compared to surrounding ceUs 
(Fig 2A) or untreated controls (Fig 2B) . T his result was also 
obtained at 10 and 250 V / m l IFN-')' (not shown). Conversely, au. ill 
silll anal ys is (Fig 3) of parallel cul tures revea led relatively unifor m 
induction of K17 tra nscripts (Fig 3A, dnrkfield; Fig 3B, lighifiefd) . 
T his discrepancy may involve cross-hybridizatio n of the K17 ill s illl 
probe with other keratins associated with hyperproliferation aJ:ld 
psoriasis, such as K16 or K6. To rule this o ut, w e tested the 
specificity of the K17 probe by ill sit ll ana lysis of frozen sections 
Figure 3. I " sit" hybridization analysis of IFN-y-induced R 1. 7 
mRNA. Darkfield (A) and lightficld (B) ;/1 S;(/1 analyses show lugh levels of 
uniform K17-spccific mcssagc throughout the confluent monolaycr afte r 
treatmcnt with 50 U/m l JFN-y. Darkficld (C) and lightfie ld (D) analyses 
dcmonstratc low levels of K17 transcripts in untreated HaCaT ce ll s. 
from psoria tic plaques. T his produced a supra basal pattern of K17 
express ion consistent with that observed previously [5] and dilte r-
ent from the basal expression pattern produced by an ilL silll probe 
specific for K6 transcripts. Furtherm o re, K17 probe specific ity was 
confirmed by detection of hig h K17 mRNA expression in basa l ce U 
carcinoma and absent expression in normal interfollicular epidermis 
(Wevers A, BOImekoh B, manuscript in preparation). T here fore , 
this comparison of the ill silll and immul1o histochemistl), data 
supports the existence of post-transcriptional regulation of K17 
protein expression. T he data also suggest that K17 protein induc-
tion by IFN-')' requires other factors , a conclusio n suggested 
previously by investigation of K6, K16, and K17 expression in 
short-term, split-thickness skin organ cul ture [23 ] . 
In this study, w e did not assess whether the effects of IFN-y are 
specific to K17 expression or other diiFerenti atio n markers of 
disease state, or affect hyperproliferation in gene ral. R ecently, 
expression of K6 and K16 has been observed after injection of 
IFN-')' in human skin [24], and altho ug h this expressio n folJowed a 
significant lag time, its presence suggests that IFN-')' can exert a 
regula tory influ ence on a variety of keratin m arkers. However, it is 
unljkely that the in II ;/ro HaCaT system wou ld be useful to assay K6 
o r K16 indu ction because one of the major and early effects of 
low-dose IFN-')' was inhibition of HaC aT proliferation and protein 
synthesis (Fig 4), and K6 and K16 have been w eU characterized as 
markers of proliferation [25] . Down- regulation of HaCaT growth 
and protein synthesis was detected at IFN-')' doses as low as 5 U /ml 
(F ig 4) and coincident w ith the induction ofK17. T lus decrease in 
proliferation has also been observed in primal)' keratinocytes [26] . 
Again, wheth er IFN-')' together with other cytokines plays a role in 
the decisio n- m akin g process of proliferation to differentia tion will 
require further study, such as assessm ent of the expression of 
differentiation markers, e.g., K1, K1D, fil a ggrin , and loricrin. In 
addition, in futu re studies tlus system m ay be useful to identify 
w luch of the signaling pathways are involved, and may identify a 
ro le for the Jak-STAT pathway, a direct nuclear signaling pathway 
associated with IFN-')' [27] . 
FinaUy, as with any in Il i tro sys te m, one sho uld use ca ution when 
extr;lpolating data to an itl I/ iJI{} situation , especiaUy one as compli-
Glted as psoriasis . Howe ver, thi s study has shown that HaCaT ce lls 
can be a re leva nt tes t system to e valu ate ke ra tin gene expressio n in 
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Figure 4. Effect ofIFN-'l' on HaCaT-cell proliferation and protein 
synthesis . Proliferation was assessed by ' /-I-th ymidine uptake; protein 
synthes is was dctermined by 14 C-amino ac id incorporation and to tal protein 
content determincd by the Bradford assay. No te that even at doses as low as 
5 U / ml, IFN--y had a signifi cant e ffect, which leveled off at approximately 
60% to 70";', contro l va lucs at 133 U / I11I. 
respo nse to cyto kine treatment, and, at least in this instance, 
demonstrated a direct link between IFN-y and K17 expression . 
Note A dded ill Proof Foll owing submission of our manuscript, 
Jiang e/ al (Mol Cell Bioi) 14:4759 - 4769, 1994) described a molec-
ular m echanism of Iymphocyte-kera tinocyte signaling in the epi-
dermis, and identified a site in the K1 7 promoter that conferred 
responsiveness to IFN-y via binding of the STAT - 91 transcription 
f.'l c tor. 
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